Mark Bodenrader serves as Executive at Cerevel Therapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Mark Bodenrader has executed 6 insider transactions totaling $389.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 1, 2024 involved selling 17,724 shares valued at $0.
Mark Bodenrader currently holds 17,724 shares of Cerevel Therapeutics Holdings, Inc. (CERE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Bodenrader has been a net seller of CERE stock. They have purchased $0 and sold $389.2K worth of shares.
Mark Bodenrader's most recent insider trade was on Aug 1, 2024, when they sold 17,724 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $41.42 |
| Discretionary |
| Dec 19, 2023 | CERE | $0 | Option Exercise | 14,199 | $N/A | Discretionary |
| Dec 19, 2023 | CERE | $0 | Option Exercise | 5,085 | $N/A | Discretionary |
| Jun 2, 2023 | CERE | $62.4K | Sale | 1,895 | $32.95 | Planned |
| Jun 1, 2023 | CERE | $0 | Option Exercise | 4,733 | $N/A | Planned |